All AbMole products are for research use only, cannot be used for human consumption.
HC-030031 is a TRPA1 selective antagonist. TRPA1 may play an important role in acute formalin and CFA induced pain. HC-030031 does not block currents mediated by TRPV1, TRPV3, TRPV4 hERG, or NaV1.2 channels. The selective TRPA1 antagonist HC-030031 can be used in cells or delivered to animals orally, by inhalation, or by injection. Oral administration of HC-030031 reduced AITC-induced nocifensive behaviors at a dose of 100 mg/kg in the rat. Moreover, oral HC-030031 (100 mg/kg) significantly reversed mechanical hypersensitivity in the more chronic models of Complete Freunds Adjuvant (CFA)-induced inflammatory pain and the spinal nerve ligation model of neuropathic pain.
 |
Source | Cancer Res (2013). Figure 1. HC-030031 |
| Method | i.g. | |
| Cell Lines | C57BL/6 mice | |
| Concentrations | 300 mg/kg | |
| Incubation Time | 60 minutes | |
| Results | Systemic treatment with HC-030031 (300 mg/kg, i.g.) at day 7 after treatment with bortezomib (0.2 or 0.5 mg/kg, i.p.) completely but transiently reverted both mechanical hyperalgesia and cold allodynia |
| Molecular Weight | 355.39 |
| Formula | C18H21N5O3 |
| CAS Number | 349085-38-7 |
| Solubility (25°C) | DMSO 27 mg/mL |
| Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
[3] McNamara CR, et al. Proc Natl Acad Sci U S A. TRPA1 mediates formalin-induced pain.
| Related TRP Channel Products |
|---|
| PF-04745637
PF-04745637 is a potent and selective TRPA1 antagonist with an IC50 of 17 nM for human TRPA1. |
| Phenazopyridine
Phenazopyridine is a competitive SARM1 inhibitor, with IC50 145 μM. Phenazopyridine is a TRPM8 antagonist. Phenazopyridine can promote neuronal differentiation and it can also be used in the research of traumatic brain injury, peripheral neuropathy and neurodegenerative diseases. |
| 4-ONE
4-ONE is one of the major hemolytic decomposition products of lipid hydroperoxides. 4-ONE is a potent transient receptor potential ankyrin 1 (TRPA1) agonist. |
| Moringin
Moringin is a potent and selective TRPA1 ion channel natural agonist with an EC50 of 3.14 μM. Moringin does not activate or activates very weakly the vanilloids somatosensory channels TRPV1, TRPV2, TRPV3 and TRPV4, and the melastatin cooling receptor TRPM8. |
| (S)-ABT-102
(S)-ABT-102 is a potent TRPV1 antagonist, with an IC50 of 123 nM. (S)-ABT-102 can block the activation of TRPV1 by capsaicin. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
